Books
in black and white
Main menu
Home About us Share a book
Books
Biology Business Chemistry Computers Culture Economics Fiction Games Guide History Management Mathematical Medicine Mental Fitnes Physics Psychology Scince Sport Technics
Ads

Methods and Principles in Medicinal Chemistry - Mannhold R.

Mannhold R., Kubinyi H., Timmerman H. Methods and Principles in Medicinal Chemistry - Wiley-VCH, 2001. - 155 p.
Download (direct link): pharmacokinetiksmedicanalchemistri2001.pdf
Previous << 1 .. 4 5 6 7 8 9 < 10 > 11 12 13 14 15 16 .. 56 >> Next

Tab. 1.1: Affinity (k) and capacity (moles drug/moles lipid) of chlorphentermine for liposomes prepared from phosphatidylcholine and phosphatidylserine.
Phospholipid k (10-4) M nmax
Phosphatidylserine 2.17 0.67
Phosphatidylcholine 1.26 0.05
12 1 Physicochemistry
References
1 Pliska V, Testa B, Van de Waterbeemd H (Eds). Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, 1996.
2 Van de Waterbeemd H, Carter RE, Grassy G, Kubinyi H, Martin YC, Tute MS, Willett P, Pure Chem. 1997, 69, 1137-1152; Ann. Rep. Med. Chem. 1998, 33, 397-409.
3 Dearden JC, Bresnen GM, Quant. Struct. Activity Relat. 1988, 7, 133-144.
4 Hersey A, Hill AP, Hyde RM, Livingstone DJ, Quant. Struct. Activity Relat.
1989, 8, 288-296.
5 Hansch C, Leo A, Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley Interscience, New York, 1979.
6 Hansch C, Leo A, Hoekman D, Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. ACS, Washington, 1995.
7 Hansch C, Leo A, Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. ACS, Washington, 1995.
8 Fujita T, Iwasa J, Hansch C, J. Amer. Chem. Soc. 1964, 86, 5175-5180.
9 Rekker RF, De Kort HM, Eur. J. Med. Chem. 1979, 14, 479-488.
10 Rekker RF, Mannhold R, Calculation of Drug Lipophilicity. VCH, Weinheim,
1992.
11 Leo A, Abraham DJ, Proteins: Struct. Funct. Gen. 1988, 2, 130-152.
12 Leo A, Hansch C, Elkins D, Chem. Rev. 1971, 71, 525-616.
13 Manners CN, Payling DW, Smith DA, Xenobiotica 1988, 18, 331-350.
14 Kulagowski JJ, Baker R, Curtis NR, Lee-son PD, Mawer IM, Moseley AM, Ridgill MP, Rowley M, Stansfield I, Foster AC, Gromwood S, Hill RG, Kemp JA, Marshall GR, Saywell KL, Tricklebank MD, J. Med. Chem. 1994, 37, 1402-1405.
15 Palm K, Luthman K, Ros J, Grasjo J, Ar-tursson P, J. Pharmacol. Exp. Ther. 1999, 291, 435-443.
16 Reymond F, Carrupt PA, Testa B,
Girault HH, Chem. Eur. J. 1999, 5,
39-47.
17 Smith RN, Hansch C, Ames MM,
J. Pharm. Sci. 1975, 64, 599-605.
18 Avdeef A, In: Lipophilicity in Drug Action and Toxicology (Eds Pliska V, Testa B, Van de Waterbeemd H), pp. 109-139. VCH, Weinheim, 1996.
19 Young RC, Mitchell RC, Brown ThH, Ganellin CR, Griffiths R, Jones M, Rana KK, Saunders D, Smith IR, Sore NE, Wilks TJ, J. Med. Chem. 1988, 31, 656-671.
20 El Tayar N, Tsai RS, Testa B, Carrupt PA. Leo A, J. Pharm. Sci. 1991, 80, 590-598.
21 Abraham MH, Chadha HS, Whiting GS, Mitchell RC, J. Pharm. Sci. 1994, 83, 1085-1100.
22 Van de Waterbeemd H, Testa B,
Adv. Drug Res. 1987, 16, 85-225.
23 Van de Waterbeemd H, In: Methods for Assessing Oral Drug Absorption
(Ed. Dressman J), Marcel Dekker, New York, 2000, pp. 31-49.
24 Abraham MH, Chadra HS, Martins F, Mitchell RC, Pestic. Sci. 1999, 55, 78-99.
25 Van de Waterbeemd H, Camenisch G, Folkers G, Raevsky OA, Quant. Struct. Activity Relat. 1996, 15, 480-490.
26 Van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA,
J. Drug Target. 1998, 6, 151-165.
27 Ter Laak AM, Tsai RS, Donne-Op den Kelder GM, Carrupt PA, Testa B, Eur. J. Pharm. Sci. 1994, 2, 373-384.
28 N'Goka V, Schlewer G, Linget JM, Chambon J-P, Wermuth C-G, J. Med. Chem. 1991, 34, 2547-2557.
29 Hamilton HW, Steinbaugh BA, Stewart BH, Chan OH, Schmid HL, Schroeder R, Ryan MJ, Keiser J, Taylor MD, Blankley CJ, Kaltenbronn JS, Wright J, Hicks J, J. Med. Chem. 1995, 38,1446-1455.
30 Camenisch G, Folkers G, Van de Waterbeemd H, Pharm. Acta Helv. 1996, 71, 309-327.
31 Camenisch G, Folkers G, Van de Waterbeemd H, Eur. J. Pharm. Sci. 1998, 6, 321-329.
32 Van de Waterbeemd H, Eur. J. Pharm. Sci. 1997, 2 (Suppl.), S26-S27.
33 Leahy DE, Taylor PJ, Wait AR, Quant. Struct. Activity Relat. 1989, 8, 17-31.
34 Leahy DE, Morris JJ, Taylor PJ, Wait AR, J. Chem. Soc. Perkin Trans. 1992, 2, 723-731.
35 Suzuki N, Yoshida Y, Watarai H, Bull. Chem. Soc. Jpn. 1982, 55, 121-125.
36 Paterson DA, Conradi RA, Hilgers AR, Vidmar ThJ, Burton PhS, Quant. Struct. Activity Relat. 1994, 13, 4-10.
37 Yang CY, Cai SJ, Liu H, Pidgeon Ch,
Adv. Drug Del. Rev. 1996, 23, 229-256.
38 Ottiger C, Wunderli-Allenspach H, Pharm. Res. 1999, 16, 643-650.
39 Balon K, Riebesehl BU, Muller BW, Pharm. Res. 1999, 16, 882-888.
40 Leo A, Chem. Rev. 1993, 93, 1281-1308.
41 Mannhold R, Rekker R.F, Dross K,
Bijloo G, De Vries G, Quant. Struct. Activity Relat. 1998, 17, 517-536.
42 Rekker RF, Mannhold R, Bijloo G,
De Vries G, Dross K, Quant. Struct. Activity Relat. 1998, 17, 537-548.
43 Kellogg GE, Joshi GS, Abraham DJ, Med. Chem. Res. 1992, 1, 444-453.
1.1 Physicochemistry and Pharmacokinetics 113
44 Viswanadhan VN, Ghose AK, Revankar GR, Robins RK, J. Chem. Inf. Comput.
Sci. 1989, 29, 163-172.
45 Ghose AK, Crippen GM, J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
46 Meylan WM, Howard PH, J. Pharm.
Soc. 1995, 84, 83-92.
47 Spessard GO, J. Chem. Inf. Comput.
Sci. 1998, 38, 55-57.
48 Buchwald P, Bodor N, Curr. Med.
Chem. 1998, 5, 353-380.
49 Carrupt PA, Testa B, Gaillard P, Rev.
Comput. Chem. 1997, 11, 241-315.
50 Van de Waterbeemd H, Mannhold R,
Previous << 1 .. 4 5 6 7 8 9 < 10 > 11 12 13 14 15 16 .. 56 >> Next